Jingya Ye
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes.
Journal: Lipids in health and disease
Published: May 08, 2023
Rare Diseases in Glycosphingolipid Metabolism.
Journal: Advances in experimental medicine and biology
Published: May 03, 2022
Novel Insight into the Relationship Between Muscle-Fat and Bone in Type 2 Diabetes Ranging from Normal Weight to Obesity.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: February 25, 2022
Impaired Insulin Clearance as the Initial Regulator of Obesity-Associated Hyperinsulinemia: Novel Insight Into the Underlying Mechanism Based on Serum Bile Acid Profiles.
Journal: Diabetes care
Published: May 12, 2021
Targeted lipidomics reveals associations between serum sphingolipids and insulin sensitivity measured by the hyperinsulinemic-euglycemic clamp.
Journal: Diabetes research and clinical practice
Published: November 07, 2020
Rare Diseases Related with Lipoprotein Metabolism.
Journal: Advances in experimental medicine and biology
Published: July 25, 2020
Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression.
Journal: Metabolism: clinical and experimental
Published: April 25, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026